Clinical trials
Psychotic Disorders trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
75 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 3 |
| 2007 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 5 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 10 |
| 2018 | 7 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 6 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 4 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 43 |
| Recruiting | 13 |
| Unknown status | 9 |
| Not yet recruiting | 5 |
| Active, not recruiting | 3 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| King's College London | 20 |
| University of Manchester | 9 |
| University of Oxford | 4 |
| University of Cambridge | 3 |
| ACADIA Pharmaceuticals Inc. | 2 |
| Alkermes, Inc. | 2 |
| Edinburgh Napier University | 2 |
| NHS Greater Glasgow and Clyde | 2 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 |
| Rene Kahn | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Psychotic Disorders | 75 |
| Schizophrenia | 36 |
| Bipolar Disorder | 8 |
| Hallucinations | 4 |
| Mental Disorders | 4 |
| Depressive Disorder | 3 |
| Inflammation | 3 |
| Personality Disorders | 3 |
| Alzheimer Disease | 2 |
| Anxiety Disorders | 2 |
Trials
Showing 1 to 25 of 75. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.